Company Overview
MERIHAND is an innovative company specializing in the development of hand rehabilitation solutions and medical devices based on musculoskeletal analysis software.
Utilizing ultra-small electrode technology, we achieve deep muscle stimulation through non-invasive methods,
providing treatment effects that distinguish us from conventional techniques.
Our precise hand joint tracking and muscle analysis technologies enable detailed assessment of a patient's functional status,
followed by highly personalized rehabilitation therapy based on diagnostic results.
By re-evaluating after therapy, we generate objective medical data that demonstrates how targeted muscle stimulation improves finger range of motion (ROM) and muscle function.
This allows for more quantitative, reliable, and evidence-based rehabilitation management.
Through our data-driven approach, MERIHAND is advancing the scientific foundation of rehabilitation and
aims to leverage accumulated medical data to develop AI-driven prognosis prediction and personalized rehabilitation programs in the future.
With continuous research and innovation, we are setting a new paradigm in the global healthcare market
and are committed to providing solutions that enhance the quality of life for patients worldwide.
Utilizing ultra-small electrode technology, we achieve deep muscle stimulation through non-invasive methods,
providing treatment effects that distinguish us from conventional techniques.
Our precise hand joint tracking and muscle analysis technologies enable detailed assessment of a patient's functional status,
followed by highly personalized rehabilitation therapy based on diagnostic results.
By re-evaluating after therapy, we generate objective medical data that demonstrates how targeted muscle stimulation improves finger range of motion (ROM) and muscle function.
This allows for more quantitative, reliable, and evidence-based rehabilitation management.
Through our data-driven approach, MERIHAND is advancing the scientific foundation of rehabilitation and
aims to leverage accumulated medical data to develop AI-driven prognosis prediction and personalized rehabilitation programs in the future.
With continuous research and innovation, we are setting a new paradigm in the global healthcare market
and are committed to providing solutions that enhance the quality of life for patients worldwide.
